You are here: Industry Insights > drugmakers

News List

US drugmakers allegedly collude on generic price hikes europeanpharmaceuticalreview
May 15, 2019
A coalition of 43 attorneys general allege generic drug manufacturers colluded, overcharging US states and consumers billions.
US states file lawsuit against 20 drugmakers accused of price-fixing pharmaceutical-technology
May 14, 2019
An antitrust lawsuit filed by 44 US states has alleged that 20 pharmaceutical companies that make generic drugs have collaborated to fix prices and reduce market competition.
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say nytimes
May 13, 2019
Leading drug companies including Teva, Pfizer, Novartis and Mylan conspired to inflate the prices of generic drugs by as much as 1,000 percent, according to a far-reaching lawsuit filed on Friday by 44 states.
US finalises rule requiring drugmakers to disclose price of medicines in TV ads firstwordpharma
May 09, 2019
US Health and Human Services Secretary Alex Azar announced Wednesday a final rule from the Centers for Medicare & Medicaid Services (CMS) that will require direct-to-consumer television advertisements for ...
US Senate invites pharmacy benefit managers to testify on drug pricing pharmaceutical-technology
March 14, 2019
The US Senate Finance Committee has invited executives from five major pharmacy benefit managers (PBMs) to testify about the rising prescription medicine costs in the country.
Pharma still puts pricing at the top of its worry list: report fiercepharma
January 08, 2019
It may not seem as if pharma companies are biting their nails over drug prices. After all, a cohort of drugmakers made headlines last week with an annual round of January hikes. But the issue is on the top of industry worries for 2019, a new report finds.
Litigation teaches Chinese valsartan maker the downside of U.S. market fiercepharma
October 10, 2018
China’s Zhejiang Huahai Pharmaceutical for years enjoyed the upside of the U.S. pharmaceutical market, selling its valsartan API to drugmakers producing blood pressure meds for the market.
The top 10 drugmakers of 2024 fiercepharma
September 26, 2018
Big Pharma will get bigger, much bigger, over the next several years, with the companies vying to grow their sales in a range of established and emerging therapeutic areas, notably cancer and immunology.
Novartis, Novo, Glaxo and others hunker down as hurricane sweeps in fiercepharma
September 14, 2018
As Hurricane Florence bore down on the southeast today, drugmakers were taking steps to keep medicine supplies flowing and employees out of harms way.
Drugmakers large and small score FDA nods in busy week of approvals fiercepharma
August 27, 2018
A group of drugmakers large and small scored FDA nods in a busy week for the agency.

Previous page 1 2 Next page